Robert Kramer
Officer, Director at Emergent BioSolutions Inc. (EBS)
Robert Kramer has filed 12 insider reports with the SEC since January 2021, as officer and director at Emergent BioSolutions Inc. (EBS). Robert Kramer made no open-market purchases or sales in the last 12 months. The latest filing, on June 14, 2023, reports grant or award at Emergent BioSolutions Inc. (EBS).
- Filings
- 12
- Companies
- 1
- Bought on market
- None
- Sold on market
- $10.1M
Companies where Robert Kramer is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer, Director | 506,059 | $10.1M | $5.81 | Jun 14, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 9, 2023EBSSEC Form 4 filed by Kramer RobertForm 4Grant or award
- Feb 28, 2023EBSSEC Form 4: Kramer Robert covered exercise/tax liability with 3,226 shares, decreasing direct ownership by 3% to 103,298 unitsForm 4Shares withheld for taxes or exercise price
- Feb 24, 2023EBSSEC Form 4: Kramer Robert covered exercise/tax liability with 3,019 shares, decreasing direct ownership by 3% to 106,524 unitsForm 4Shares withheld for taxes or exercise price
- Feb 8, 2023EBSSEC Form 4: Kramer Robert was granted 278 shares and covered exercise/tax liability with 4,944 shares, decreasing direct ownership by 4% to 109,543 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Mar 1, 2022EBSSEC Form 4: Kramer Robert was granted 89,415 shares and covered exercise/tax liability with 1,715 shares, increasing direct ownership by 55% to 246,969 units (tax withholding)Form 4Grant or awardShares withheld for taxes or exercise price
- Feb 22, 2022EBSSEC Form 4: Kramer Robert was granted 4,264 shares and covered exercise/tax liability with 4,595 shares, decreasing direct ownership by 0.20% to 162,722 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- May 8, 2021EBSSEC Form 4: Kramer Robert disposed of $5,792 worth of Common Stock (94 units at $61.62), decreasing direct ownership by 0.06% to 163,053 unitsForm 4Shares withheld for taxes or exercise price
- Feb 26, 2021EBSSEC Form 4: Robert Kramer was granted 29,950 units of Common Stock and disposed of $476,972 worth of Common Stock (5,001 units at $95.38), increasing ownership by 18% to 163,147 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 9, 2021EBSSEC Form 4: Robert Kramer was granted 3,281 units of Common Stock and disposed of $529,971 worth of Common Stock (4,293 units at $123.45), decreasing ownership by 0.73% to 138,198 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 8, 2021-$5.45MEBSSEC Form 4: Robert Kramer exercised 45,397 units of Common Stock at a strike of $30.79 and sold $5,449,002 worth of Common Stock (45,397 units at $120.03)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jan 21, 2021-$2.66MEBSSEC Form 4: Robert Kramer exercised 24,132 units of Common Stock at a strike of $26.45 and sold $2,654,882 worth of Common Stock (24,132 units at $110.02)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jan 15, 2021-$2.02MEBSSEC Form 4: Robert Kramer sold $2,016,901 worth of Common Stock (19,026 units at $106.01) and exercised 19,026 units of Common Stock at a strike of $25.62Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
Compare Robert Kramer with
- Robert Kramer vs Paul Anthony Williams1 shared
- Robert Kramer vs Richard S Lindahl1 shared
- Robert Kramer vs Coleen Glessner1 shared
- Robert Kramer vs William Hartzel1 shared
- Robert Kramer vs Sujata Tyagi Dayal1 shared
- Robert Kramer vs Donald W DeGolyer1 shared
Other insiders at the same companies
- Paul Anthony WilliamsEBS
- Stephanie DuatschekEBS
- Richard S LindahlEBS
- Coleen GlessnerEBS
- William HartzelEBS
- Sujata Tyagi DayalEBS
- Donald W DeGolyerEBS
- Keith KatkinEBS
- Marvin L WhiteEBS
- John D Fowler JrEBS
- Ronald RichardEBS
- Kathryn C ZoonEBS
- Neal Franklin FowlerEBS
- Zsolt HarsanyiEBS
- Simon C LowryEBS
- Jessica PerlEBS
Questions about Robert Kramer
- What is Robert Kramer's role at Emergent BioSolutions Inc.?
- Robert Kramer reports to the SEC as officer and director at Emergent BioSolutions Inc. (EBS), according to the latest filing on June 14, 2023.
- How many shares does Robert Kramer own?
- After the latest filing that states it, Robert Kramer directly owned 506,059 shares of Emergent BioSolutions Inc. (EBS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robert Kramer bought or sold stock recently?
- The most recent open-market sale was on February 8, 2021: sold 45,397 shares of Emergent BioSolutions Inc. (EBS) for $5.45M at an average of $120.03.
- How do I get alerts when Robert Kramer files?
- Follow Robert Kramer on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Robert Kramer (SEC CIK 0001380956). Totals count each trade once, skipping amendments whose original is on file, from Jan 19, 2021 on. View on SEC EDGAR